In-depth research guides covering peptides, compounds, and laboratory supplies. For research use only.
The Evolution From Single to Triple Receptor Targeting The development of GLP-1 receptor agonists represents one of the most significant advances in metabolic research over the past decade. What began with single-receptor compounds like semaglutide has rapidly evolved into dual and triple agonists that target multiple metabolic pathways simultaneously — each generation producing larger effect…
Considering switching from tirzepatide to retatrutide? Compare the dual vs triple agonist mechanisms, clinical trial data, dosing protocols, and what researchers are reporting.
Most people notice appetite changes within 1-2 weeks on retatrutide. Here’s the full timeline.
Can you drink alcohol on peptides? What the research says about GLP-1s, BPC-157, and NAD+.
A concise comparison of Sermorelin and CJC-1295 — two GHRH-based peptides with different half-lives, mechanisms, and research applications.
A concise comparison of BPC-157 and TB-500 — their distinct mechanisms, research applications, and why they are often studied together.
Standard workplace drug tests don’t test for peptides. Athletic testing is a different story.
Most research peptides require injection, but nasal sprays, oral, and topical options exist for some.
A concise overview of Selank — the synthetic anxiolytic peptide based on tuftsin, its mechanism of action, and key neuropeptide research findings.
What Does the Research Say About Peptides and Aging? Aging research has undergone a fundamental shift over the past two decades. Once considered an inevitable, untreatable process, biological aging is now understood as a collection of measurable, interconnected mechanisms — telomere shortening, mitochondrial dysfunction, cellular senescence, NAD+ decline, and gene expression changes. Each of these…
